These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38621458)

  • 1. Cross-talk between BCKDK-mediated phosphorylation and STUB1-dependent ubiquitination degradation of BCAT1 promotes GBM progression.
    Wang W; Li Y; Tang L; Shi Y; Li W; Zou L; Zhang L; Cheng Y; Yuan Z; Zhu F; Duan Q
    Cancer Lett; 2024 Jun; 591():216849. PubMed ID: 38621458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E3 ubiquitin ligase STUB1 attenuates cell senescence by promoting the ubiquitination and degradation of the core circadian regulator BMAL1.
    Ullah K; Chen S; Lu J; Wang X; Liu Q; Zhang Y; Long Y; Hu Z; Xu G
    J Biol Chem; 2020 Apr; 295(14):4696-4708. PubMed ID: 32041778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHIP promotes CAD ubiquitination and degradation to suppress the proliferation and colony formation of glioblastoma cells.
    Li G; Xiao K; Li Y; Gao J; He S; Li T
    Cell Oncol (Dordr); 2024 Jun; 47(3):851-865. PubMed ID: 37982961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma.
    Li H; Li J; Chen L; Qi S; Yu S; Weng Z; Hu Z; Zhou Q; Xin Z; Shi L; Ma L; Huang A; Lu Y
    Clin Cancer Res; 2019 Jun; 25(12):3602-3616. PubMed ID: 30862693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression.
    Zhou P; Peng X; Tang S; Zhang K; Tan Z; Li D; Shen L; Peng J; Yang L
    Oncogene; 2023 Apr; 42(16):1308-1320. PubMed ID: 36882523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance.
    Li Y; Wang T; Wan Q; Wang Q; Chen Z; Gao Y; Ye Y; Lin J; Zhao B; Wang H; Yang J; Zhao K; Lu N
    Cancer Res; 2022 Oct; 82(19):3573-3587. PubMed ID: 35895752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth.
    Feng X; Jia Y; Zhang Y; Ma F; Zhu Y; Hong X; Zhou Q; He R; Zhang H; Jin J; Piao D; Huang H; Li Q; Qiu X; Zhang Z
    Autophagy; 2019 Jul; 15(7):1130-1149. PubMed ID: 30686098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
    Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
    Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2-HO-1 Axis.
    Chuang HY; Hsu LY; Pan CM; Pikatan NW; Yadav VK; Fong IH; Chen CH; Yeh CT; Chiu SC
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
    Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G
    J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PUF60 promotes glioblastoma progression through regulation of EGFR stability.
    Wang F; Peng L; Sun Y; Zhang B; Lu S
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):190-196. PubMed ID: 36335869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.
    Yi L; Fan X; Li J; Yuan F; Zhao J; Nistér M; Yang X
    Aging (Albany NY); 2021 Jan; 13(3):3645-3660. PubMed ID: 33493139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma.
    Zhang Z; Wang Z; Huang K; Liu Y; Wei C; Zhou J; Zhang W; Wang Q; Liang H; Zhang A; Wang G; Zhen Y; Han L
    Cancer Lett; 2019 Feb; 443():91-107. PubMed ID: 30529153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
    Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J
    Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression.
    Peng W; Shi S; Zhong J; Liang H; Hou J; Hu X; Wang F; Zhang J; Geng S; Sun X; Zhong D; Cui H
    Oncogene; 2022 May; 41(22):3051-3063. PubMed ID: 35459780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
    Hou J; Deng Q; Zhou J; Zou J; Zhang Y; Tan P; Zhang W; Cui H
    Oncogene; 2017 Feb; 36(8):1134-1144. PubMed ID: 27546621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.
    Tönjes M; Barbus S; Park YJ; Wang W; Schlotter M; Lindroth AM; Pleier SV; Bai AHC; Karra D; Piro RM; Felsberg J; Addington A; Lemke D; Weibrecht I; Hovestadt V; Rolli CG; Campos B; Turcan S; Sturm D; Witt H; Chan TA; Herold-Mende C; Kemkemer R; König R; Schmidt K; Hull WE; Pfister SM; Jugold M; Hutson SM; Plass C; Okun JG; Reifenberger G; Lichter P; Radlwimmer B
    Nat Med; 2013 Jul; 19(7):901-908. PubMed ID: 23793099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STUB1 promotes the degradation of HSPB1 and induces ferroptosis in lung cancer cells.
    Tieliwaerdi A; Aini A; Amuti M; Aierken Y; Nijiati M; Luo B
    Environ Toxicol; 2024 Aug; 39(8):4156-4170. PubMed ID: 38661247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.